G. Aithal

First name
G.
Middle name
P.
Last name
Aithal
Nakafero, G., Grainge, M. J., Card, T., Mallen, C. D., Riley, R., van der Windt, D., et al. (2022). Incidence and pattern of mycophenolate discontinuation associated with abnormal monitoring blood-test results: cohort study using data from the Clinical Practice Research Datalink Aurum. Rheumatol Adv Pract, 6, rkac046. http://doi.org/10.1093/rap/rkac046
Lawson, A., West, J., Aithal, G. P., & Logan, R. F. (2005). Autoimmune cholestatic liver disease in people with coeliac disease: a population-based study of their association. Aliment Pharmacol Ther. http://doi.org/10.1111/j.1365-2036.2005.02328.x
Solaymani-Dodaran, M., Card, T. R., Aithal, G. P., & West, J. (2006). Fracture risk in people with primary biliary cirrhosis: a population-based cohort study. Gastroenterology. http://doi.org/10.1053/j.gastro.2006.09.012
Jackson, H., Solaymani-Dodaran, M., Card, T. R., Aithal, G. P., Logan, R., & West, J. (2007). Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study. Hepatology. http://doi.org/10.1002/hep.21795
Solaymani-Dodaran, M., Aithal, G. P., Card, T., & West, J. (2008). Risk of cardiovascular and cerebrovascular events in primary biliary cirrhosis: a population-based cohort study. Am J Gastroenterol. http://doi.org/10.1111/j.1572-0241.2008.02092.x
Fleming, K. M., Aithal, G. P., Card, T. R., & West, J. (2010). The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study. Aliment Pharmacol Ther. http://doi.org/10.1111/j.1365-2036.2010.04473.x
Fleming, K. M., Aithal, G. P., Card, T. R., & West, J. (2012). All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study. Liver Int. http://doi.org/10.1111/j.1478-3231.2011.02517.x
Ratib, S., Fleming, K. M., Crooks, C. J., Aithal, G. P., & West, J. (2014). 1 and 5 year survival estimates for people with cirrhosis of the liver in England, 1998-2009: a large population study. J Hepatol. http://doi.org/10.1016/j.jhep.2013.09.027
West, J., Card, T. R., Aithal, G. P., & Fleming, K. M. (2017). Risk of hepatocellular carcinoma among individuals with different aetiologies of cirrhosis: a population-based cohort study. Aliment Pharmacol Ther. http://doi.org/10.1111/apt.13961
Nakafero, G., Grainge, M. J., Card, T., Mallen, C. D., Zhang, W., Doherty, M., et al. (2021). What is the incidence of methotrexate or leflunomide discontinuation related to cytopenia, liver enzyme elevation or kidney function decline?. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/keab254